Real-time enrollment status for this anaplastic large cell lymphoma, alk-negative clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:08 PM UTC
| NCT Number | NCT06724237 |
| Recruiting Status | Recruiting |
| Condition | Anaplastic Large Cell Lymphoma, ALK-Negative |
| Phase | Clinical Trial |
| Target Enrollment | 294 participants |
| Active Locations | 158 sites in the US |
| Sponsor | Eastern Cooperative Oncology Group |
| Last Updated on CT.gov | June 18, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT06724237 is currently recruiting participants. This clinical trial study for anaplastic large cell lymphoma, alk-negative is actively seeking new participants at 158 locations across the United States. The study is sponsored by Eastern Cooperative Oncology Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06724237 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 158 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06724237 was last updated 3 weeks ago (June 18, 2026). HelloStudys verifies this status automatically.